Nutex Health ROE 2016-2025 | NUTX
Current and historical return on equity (ROE) values for Nutex Health (NUTX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Nutex Health ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $0.07B | $0.28B | 42.57% |
| 2024-12-31 | $0.05B | $0.20B | 47.75% |
| 2024-09-30 | $-0.04B | $0.08B | -51.09% |
| 2024-06-30 | $-0.04B | $0.08B | -43.93% |
| 2024-03-31 | $-0.04B | $0.08B | -44.09% |
| 2023-12-31 | $-0.05B | $0.08B | -45.77% |
| 2023-09-30 | $-0.03B | $0.11B | -26.19% |
| 2023-06-30 | $-0.44B | $0.11B | -369.43% |
| 2023-03-31 | $-0.45B | $0.11B | -194.19% |
| 2022-12-31 | $-0.43B | $0.12B | -190.58% |
| 2022-09-30 | $-0.35B | $0.13B | -146.89% |
| 2022-06-30 | $0.11B | $0.57B | 49.50% |
| 2022-03-31 | $0.16B | $0.07B | 155.67% |
| 2021-12-31 | $0.13B | $0.19B | 133.33% |
| 2021-09-30 | $0.18B | $0.07B | 353.40% |
| 2021-06-30 | $0.13B | $0.07B | 379.56% |
| 2021-03-31 | $0.10B | $0.07B | 542.11% |
| 2020-12-31 | $0.11B | $0.00B | 3533.33% |
| 2020-09-30 | $0.00B | $0.01B | -80.00% |
| 2020-06-30 | $-0.01B | $0.01B | -218.18% |
| 2020-03-31 | $-0.01B | $0.00B | -533.33% |
| 2019-12-31 | $-0.01B | $0.00B | -640.00% |
| 2019-09-30 | $0.00B | $0.00B | -600.00% |
| 2019-06-30 | $0.00B | $0.00B | -400.00% |
| 2019-03-31 | $0.00B | $0.00B | -200.00% |
| 2018-12-31 | $0.00B | $0.00B | -160.00% |
| 2018-09-30 | $-0.01B | $0.00B | -350.00% |
| 2018-06-30 | $0.00B | $0.00B | 0.00% |
| 2018-03-31 | $0.00B | $0.00B | -25.00% |
| 2017-12-31 | $0.00B | $0.00B | 0.00% |
| 2017-09-30 | $0.00B | $0.01B | -200.00% |
| 2017-06-30 | $-0.01B | $0.01B | 0.00% |
| 2017-03-31 | $-0.01B | $0.00B | 466.67% |
| 2016-12-31 | $-0.01B | $-0.01B | 466.67% |
| 2016-06-30 | $0.00B | $0.00B | 0.00% |
| 2016-03-31 | $0.00B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.658B | $0.480B |
| Nutex Health Inc. is a physician-led, technology-enabled healthcare services company. The Company's operating divisions include Hospital division and Population Health Management division. Hospital division implements and operates different health care models, including micro hospitals, specialty hospitals and hospital outpatient departments. Population Health Management division owns and operates provider networks such as Independent Physician Associations. Nutex Health Inc., formerly known as Clinigence Holdings Inc., is based in HOUSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $145.424B | 27.27 |
| CVS Health (CVS) | United States | $85.300B | 10.60 |
| Elevance Health (ELV) | United States | $78.589B | 10.14 |
| Cencora (COR) | United States | $57.416B | 19.98 |
| DiDi Global (DIDIY) | China | $22.826B | 24.25 |
| Natera (NTRA) | United States | $22.088B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.920B | 17.78 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.673B | 0.00 |
| Solventum (SOLV) | United States | $13.582B | 14.38 |
| CochLear (CHEOY) | Australia | $12.960B | 0.00 |
| ICON (ICLR) | Ireland | $12.122B | 11.27 |
| Revvity (RVTY) | United States | $11.941B | 20.55 |
| Viatris (VTRS) | United States | $10.939B | 3.76 |
| Avantor (AVTR) | United States | $9.458B | 13.74 |
| Medpace Holdings (MEDP) | United States | $9.240B | 24.54 |
| HealthEquity (HQY) | United States | $8.834B | 38.70 |
| Sonic Healthcare (SKHHY) | Australia | $8.518B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.717B | 15.12 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.752B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.910B | 28.92 |
| BrightSpring Health Services (BTSG) | United States | $3.889B | 35.68 |
| Sotera Health (SHC) | United States | $3.334B | 18.94 |
| Surgery Partners (SGRY) | United States | $2.839B | 36.92 |
| Alignment Healthcare (ALHC) | United States | $2.685B | 0.00 |
| Concentras Parent (CON) | United States | $2.635B | 15.23 |
| GeneDx Holdings (WGS) | United States | $2.614B | 100.67 |
| Organon (OGN) | United States | $2.589B | 2.75 |
| PACS (PACS) | United States | $2.003B | 0.00 |
| Ardent Health (ARDT) | United States | $1.915B | 8.16 |
| Progyny (PGNY) | United States | $1.840B | 40.49 |
| Premier (PINC) | United States | $1.812B | 13.76 |
| GoodRx Holdings (GDRX) | United States | $1.682B | 33.64 |
| Teladoc Health (TDOC) | United States | $1.454B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.259B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.184B | 9.01 |
| CareDx (CDNA) | United States | $1.071B | 16.73 |
| Agilon Health (AGL) | United States | $1.006B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.839B | 7.86 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.603B | 4.06 |
| InnovAge Holding (INNV) | United States | $0.602B | 0.00 |
| LifeMD (LFMD) | United States | $0.568B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.481B | 0.00 |
| Omada Health (OMDA) | $0.480B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.55 |
| SBC Medicals (SBC) | United States | $0.463B | 0.00 |
| Enhabit (EHAB) | United States | $0.387B | 31.88 |
| So-Young (SY) | China | $0.330B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.328B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.305B | 0.00 |
| Beauty Health (SKIN) | United States | $0.287B | 0.00 |
| Oncology Institute (TOI) | United States | $0.225B | 0.00 |
| DocGo (DCGO) | United States | $0.161B | 26.33 |
| Pheton Holdings (PTHL) | China | $0.126B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.094B | 0.00 |
| KindlyMD (NAKA) | United States | $0.077B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.032B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.026B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |